These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35237060)

  • 21. A Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease.
    Aksoy E; Güngör S; Ağca MÇ; Özmen İ; Duman D; Koçak ND; Aktürk ÜA; Tunçay E; Saltürk C; Yalçınsoy M; Ocaklı B; Karakurt Z
    Turk Thorac J; 2018 Oct; 19(4):193-200. PubMed ID: 30322438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low and High Blood Eosinophil Counts as Biomarkers in Hospitalized Acute Exacerbations of COPD.
    MacDonald MI; Osadnik CR; Bulfin L; Hamza K; Leong P; Wong A; King PT; Bardin PG
    Chest; 2019 Jul; 156(1):92-100. PubMed ID: 30978330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators.
    Lu FY; Chen R; Li N; Sun XW; Zhou M; Li QY; Guo Y
    Int J Chron Obstruct Pulmon Dis; 2021; 16():341-349. PubMed ID: 33633446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
    Cui Y; Zhang W; Ma Y; Zhan Z; Chen Y
    Respir Res; 2021 Nov; 22(1):301. PubMed ID: 34819051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease.
    Wang Y; Chang C; Tian S; Wang J; Gai X; Zhou Q; Chen Y; Gao X; Sun Y; Liang Y
    Front Mol Biosci; 2023; 10():1204985. PubMed ID: 37503537
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Community-Acquired Pneumonia on Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Niu Y; Xing Y; Li J; Shui W; Gu Y; Zhang C; Du H
    COPD; 2021 Aug; 18(4):417-424. PubMed ID: 34309464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the total serum IgE levels in patients with acute exacerbations chronic obstructive pulmonary disease: A retrospective study.
    Xie X; Zheng J; Li Z; Qi J; Li L; Yuan L; Jiang T; Yang Z; Qin S; Tian X; Wang Y; Zhao P
    Medicine (Baltimore); 2024 Apr; 103(16):e37792. PubMed ID: 38640281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Yu S; Zhang J; Fang Q; Tong Z
    Am J Med Sci; 2021 Jul; 362(1):56-62. PubMed ID: 33617785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.
    Hunter LC; Lee RJ; Butcher I; Weir CJ; Fischbacher CM; McAllister D; Wild SH; Hewitt N; Hardie RM
    BMJ Open; 2016 Jan; 6(1):e009121. PubMed ID: 26801463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How may we improve clinical outcomes for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease? A narrative review about possible therapeutic and preventive strategies.
    Crisafulli E; Manco A; Torres A
    Expert Rev Respir Med; 2020 May; 14(5):493-500. PubMed ID: 32077337
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients.
    Li T; Gao L; Ma HX; Wei YY; Liu YH; Qin KR; Wang WT; Wang HL; Pang M
    Exp Biol Med (Maywood); 2020 Aug; 245(14):1290-1298. PubMed ID: 32493123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.
    Jing Z; Chun C; Ning S; Hong Z; Bei H; Wan-Zhen Y
    Arch Bronconeumol; 2016 Mar; 52(3):138-44. PubMed ID: 26002550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Enaud R; Sioniac P; Imbert S; Janvier PL; Camino A; Bui HN; Pillet O; Orieux A; Boyer A; Berger P; Gruson D; Delhaes L; Prevel R
    Microbiol Spectr; 2023 Mar; 11(2):e0506222. PubMed ID: 36976010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Hegewald MJ; Horne BD; Trudo F; Kreindler JL; Chung Y; Rea S; Blagev DP
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2629-2641. PubMed ID: 33122901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
    Nishimura K; Nishimura T; Onishi K; Oga T; Hasegawa Y; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2014; 9():155-62. PubMed ID: 24523584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study.
    Kaleem Ullah M; Parthasarathi A; Biligere Siddaiah J; Vishwanath P; Upadhyay S; Ganguly K; Anand Mahesh P
    Toxics; 2022 Nov; 10(11):. PubMed ID: 36355958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?
    Pazarli AC; Koseoglu HI; Doruk S; Sahin S; Etikan I; Celikel S; Berktas B
    J Res Med Sci; 2012 Nov; 17(11):1047-51. PubMed ID: 23833579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China.
    Cui Y; Zhan Z; Zeng Z; Huang K; Liang C; Mao X; Zhang Y; Ren X; Yang T; Chen Y
    Front Med (Lausanne); 2021; 8():653777. PubMed ID: 34179040
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients.
    Liu S; Liu M; Dong L
    J Clin Lab Anal; 2020 Sep; 34(9):e23410. PubMed ID: 32583510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.